skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 next page
Refinado por: Base de dados/Biblioteca: BACON - Mir@bel - GLOBAL_LIBRESACCES remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors

Chowdhury, Simon ; Mainwaring, Paul ; Zhang, Liangcai ; Mundle, Suneel ; Pollozi, Eneida ; Gray, Alexander ; Wildgust, Mark

Frontiers in oncology, 2020-08, Vol.10, p.1349-1349 [Periódico revisado por pares]

Frontiers Research Foundation

Texto completo disponível

Citações Citado por
2
Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma
Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma

Campbell, Belinda A. ; Scarisbrick, Julia J. ; Kim, Youn H. ; Wilcox, Ryan A. ; McCormack, Christopher ; Prince, H. Miles

Cancers, 2020-08, Vol.12 (8), p.2311 [Periódico revisado por pares]

Basel: MDPI AG

Texto completo disponível

Citações Citado por
3
Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers
Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers

Krendyukov, Andriy ; Singhvi, Sanjay ; Zabransky, Markus

Frontiers in oncology, 2021-03, Vol.11, p.636561-636561 [Periódico revisado por pares]

Switzerland: Frontiers Media S.A

Texto completo disponível

Citações Citado por
4
Secretory leukocyte protease inhibitor as a novel predictive biomarker in patients with diabetic kidney disease
Secretory leukocyte protease inhibitor as a novel predictive biomarker in patients with diabetic kidney disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Secretory leukocyte protease inhibitor as a novel predictive biomarker in patients with diabetic kidney disease

Sun, Weiwei ; Yang, Hanwen ; Zhang, Jiale ; Wei, Shuwu ; Wu, Qiaoru ; Yang, Jie ; Cao, Can ; Cui, Zhaoli ; Zheng, Huijuan ; Wang, Yaoxian

Frontiers in endocrinology (Lausanne), 2024, Vol.15, p.1334418-1334418 [Periódico revisado por pares]

Switzerland: Frontiers Media S.A

Texto completo disponível

Citações Citado por
5
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR

Terheyden, Jan H ; Holz, Frank G ; Schmitz-Valckenberg, Steffen ; Lüning, Anna ; Schmid, Matthias ; Rubin, Gary S ; Dunbar, Hannah ; Tufail, Adnan ; Crabb, David P ; Binns, Alison ; Sánchez, Clara I ; Hoyng, Carel ; Margaron, Philippe ; Zakaria, Nadia ; Durbin, Mary ; Luhmann, Ulrich ; Zamiri, Parisa ; Cunha-Vaz, José ; Martinho, Cecília ; Leal, Sergio ; Finger, Robert P

Current controlled trials in cardiovascular medicine, 2020-07, Vol.21 (1), p.659-659, Article 659 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
6
Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection
Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection

Hedetoft, Morten ; Hansen, Marco Bo ; Madsen, Martin Bruun ; Johansen, Julia Sidenius ; Hyldegaard, Ole

BMC infectious diseases, 2021-10, Vol.21 (1), p.1046-1046, Article 1046 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis
Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis

Palathumpattu, Binoy ; Pieper‐Fürst, Ursula ; Acikel, Cengizhan ; Sahin, Hacer ; Allekotte, Silke ; Singh, Jaswinder ; Hess, Mark ; Sager, Angelika ; Müller, Thomas ; Mösges, Ralph

Clinical and translational allergy, 2022-10, Vol.12 (10), p.e12191-n/a [Periódico revisado por pares]

Hoboken: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
8
Dealing with prognostic signature instability: a strategy illustrated for cardiovascular events in patients with end-stage renal disease
Dealing with prognostic signature instability: a strategy illustrated for cardiovascular events in patients with end-stage renal disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dealing with prognostic signature instability: a strategy illustrated for cardiovascular events in patients with end-stage renal disease

Binder, Harald ; Kurz, Thorsten ; Teschner, Sven ; Kreutz, Clemens ; Geyer, Marcel ; Donauer, Johannes ; Kraemer-Guth, Annette ; Timmer, Jens ; Schumacher, Martin ; Walz, Gerd

BMC medical genomics, 2016-07, Vol.9 (1), p.43-43, Article 43 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
9
A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables
A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables

Jiang, Zhiwei ; Song, Yang ; Shou, Qiong ; Xia, Jielai ; Wang, William

Trials, 2014-12, Vol.15 (1), p.500-500, Article 500 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
Updating clinical endpoint definitions
Updating clinical endpoint definitions
Material Type:
Artigo 		Adicionar ao Meu Espaço

Updating clinical endpoint definitions

Hassoun, Paul M. ; Nikkho, Sylvia ; Rosenzweig, Erika B. ; Moreschi, Gail ; Lawrence, John ; Teeter, John ; Meier, Christian ; Ghofrani, Ardeshir H. ; Minai, Omar ; Rinaldi, Paula ; Michelakis, Evangelos ; Oudiz, Ronald J

Pulmonary circulation, 2013-01, Vol.3 (1), p.206-216 [Periódico revisado por pares]

London, England: University of Chicago Press

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2005  (2)
  2. 2005Até2013  (3)
  3. 2014Até2017  (2)
  4. 2018Até2021  (10)
  5. Após 2021  (6)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.